Top compounds associated with response to TLDC2


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 2e-05
mRNA CHEMBL1222381 CTRPv2 pan-cancer AAC 0.15 3e-05
mRNA TW 37 GDSC1000 pan-cancer AAC -0.15 5e-05
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 7e-05
mRNA Docetaxel GDSC1000 pan-cancer AAC -0.13 8e-05
mRNA GSK1120212 CTRPv2 pan-cancer AAC 0.21 0.0001
mRNA austocystin d CTRPv2 pan-cancer AAC 0.15 0.0001
mRNA selumetinib:JQ-1 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 0.0002
mRNA RITA CTRPv2 pan-cancer AAC 0.14 0.0002
mRNA GDC-0879 CTRPv2 pan-cancer AAC 0.14 0.0003
Download CSV